JBIO
Jade Biosciences
JBIO
JBIO
45 hedge funds and large institutions have $475M invested in Jade Biosciences in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
4% less funds holding
Funds holding: 47 → 45 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Holders
45
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$4.37M | |
| 2 | +$2.77M | |
| 3 | +$1.83M | |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$1.23M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$686K |
Top Sellers
| 1 | -$1.2M | |
| 2 | -$1.17M | |
| 3 | -$472K | |
| 4 |
PL
Parkwood LLC
Cleveland,
Ohio
|
-$438K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$424K |